RETRACTED: LEF-1 gene silencing inhibits pulmonary vascular remodeling and occurrence of pulmonary arterial hypertension through the β-catenin signaling pathway-Reference-Cited by-同舟云学术

RETRACTED: LEF-1 gene silencing inhibits pulmonary vascular remodeling and occurrence of pulmonary arterial hypertension through the β-catenin signaling pathway

Published:2018-12 Issue: Volume:108 Page:817-827
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Zhang Xian-Feng,Yang Yang,Yang Xin-Yu,Tong Qian

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference33 articles.

1. Riociguat for the treatment of pulmonary arterial hypertension: a long-term extension study (PATENT-2);Rubin;Eur. Respir. J.,2015

2. Connective tissue disease-associated pulmonary arterial hypertension;Condliffe;F1000Prime Rep.,2015

3. Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and Ireland;Ling;Am. J. Respir. Crit. Care Med.,2012

4. Air pollution exposure: a novel environmental risk factor for interstitial lung disease?;Johannson;Chest,2015

5. Exposure to household air pollution from wood combustion and association with respiratory symptoms and lung function in nonsmoking women: results from the RESPIRE trial, Guatemala;Pope;Environ. Health Perspect.,2015

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polyphyllin VII alleviates pulmonary hypertension by inducing miR-205–5p to target the β-catenin pathway;Biomedicine & Pharmacotherapy;2023-11

2. Interferon regulatory factor 7 inhibits rat vascular smooth muscle cell proliferation and inflammation in monocrotaline-induced pulmonary hypertension;Life Sciences;2021-01

3. Retraction notice to “LEF-1 gene silencing inhibits pulmonary vascular remodeling and occurrence of pulmonary arterial hypertension through the β-catenin signaling pathway” [Biomed. Pharmacother. 108 (2018) 817–827];Biomedicine & Pharmacotherapy;2020-08

4. RETRACTION;Physiological Genomics;2019-11-01